Vista Partners Initiates Coverage on MediciNova Inc. (Nasdaq: MNOV)
LOS ANGELES, July 16 /PRNewswire-FirstCall/ -- Vista Partners announced
today that it has initiated coverage on MediciNova
Inc. (Nasdaq: MNOV ).
"MediciNova has a promising drug development pipeline for treating a
variety of diseases and conditions. The Company is primarily focused on two
Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meeting of Stockholders
...onths ago. We also wish to acknowledge the constructive and bold efforts of medicinova
throughout this process. We encourage Avigen to engage with medicinova
during the liquidation process; we intend to be helpful in this regard."
Leading Advisory Firm, PROXY Governance, Recommends Avigen Shareholders Vote on GOLD Card to Remove Incumbent Directors and Elect BVF's Stockholder-Oriented Nominees
...ffer which guaranteed the liquidity downside because - as a fund with a clear fiduciary obligation to its investors, and no economic relationship with medicinova
- their interests are clearly aligned with all other shareholders in the pursuit of that goal."
Mark Lampert, BVF Partner, stated, "We are gratif...
Empirical Search Strategies Seeks Downside Protection Option at Avigen, Inc.
... are limited, management should publically state they will either (i) distribute this excess cash immediately, or (ii) structure a deal similar to the medicinova
deal that offers shareholders an exit option for a specific amount and at a specific time in the future.
Third, Avigen is...
Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value
...essively Pursued The COMPELLING Merger Proposal By medicinova
That Offered BOTH Downside Protection AND Signific...e the current Board, we believe that a merger with medicinova
makes sense for all Avigen stockholders and we can...rdinary potential benefits we see in a merger with medicinova
Downside Protection : Bas...
Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders
... believe that Avigen intends to gamble that money. medicinova
has proposed a transaction that offers critical do...rectly?
3. Why does Avigen not consider the medicinova
proposed merger to be a compelling outcome for sto... understand why Avigen appears to be resisting the medicinova
transaction. Economically, based on publicly avai...
Biotechnology Value Fund, L.P. To Make Tender Offer For Any And All Outstanding Shares Of Avigen At $1.00 Per Share
...s are elected
BVF reaffirms support for downside-protected merger with medicinova
NEW YORK, Jan. 15 /PRNewswire/ -- Biotechnology Value Fund, L.P. ("BV...'t change the fact that the risk-reward profile of the proposed merger with medicinova
is extraordinary. We are concerned that this is just another example of the...
Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees
...on our analysis, subsequent to the transaction, if medicinova
is unsuccessful Avigen stockholders will receive a...dous Upside Potential: Based on our analysis, if medicinova
is successful post-transaction, Avigen stockholders could own a substantial percentage of medicinova
- approximately 45% of the combined company. Unde...